Cholinergic modulation of nociceptive responses in vivo and neuropeptide release in vitro at the level of the primary sensory neuron

Pain

Volumn 107, Issue 1-2, 2004, Pages 22-32

  Dussor, Gregory O ^a   Helesic, Gabriela ^a   Hargreaves, Kenneth M ^a   Flores, Christopher M ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Capsaicin; Formalin; Inflammation; Muscarinic receptor; Nociception; Sensory neuron

Indexed keywords

ACETYLCHOLINE; ARECAIDINE; ATROPINE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CAPSAICIN; FORMALDEHYDE; GALLAMINE; LIGAND; MESSENGER RNA; MUSCARINE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; NEUROPEPTIDE; VANILLOID RECEPTOR 1;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CHEEK MUCOSA; CHOLINERGIC SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEFENSE MECHANISM; DRUG EFFECT; DRUG POTENTIATION; DRUG SELECTIVITY; EVOKED RESPONSE; EXPERIMENTAL MODEL; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; INJECTION SITE; MALE; NEUROMODULATION; NOCICEPTION; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; RECEPTOR BLOCKING; SENSORY NERVE CELL; TRIGEMINAL NERVE; TRIGEMINUS GANGLION;

EID: 0346724925     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2003.09.022     Document Type: Article

References (36)

1. Averill S., McMahon S.B., Clary D.O., Reichardt L.F., Priestley J.V. Immunocytochemical localization of trkA receptors in chemically identified subgroups of adult rat sensory neurons. Eur J Neurosci. 7:1995;1484-1494.
2. Bernardini N., Levey A.I., Augusti-Tocco G. Rat dorsal root ganglia express m1-m4 muscarinic receptor proteins. J Peripher Nerv Syst. 4:1999;222-232.
3. Bernardini N., Reeh P.W., Sauer S.K. Muscarinic m2 receptors inhibit heat-induced CGRP release from isolated rat skin. NeuroReport. 12:2001;2457-2460.
4. Bernardini N., Sauer S.K., Haberberger R., Fischer M.J.M., Reeh P.W. Excitatory nicotinic and desensitizing muscarinic (m2) effects on c-nociceptors in isolated rat skin. J Neurosci. 21:2001;3295-3302.
5. Bernardini N., Roza C., Sauer S.K., Gomeza J., Wess J., Reeh P.W. Muscarinic m2 receptors on peripheral nerve endings: a molecular target of antinociception. J Neurosci. 22:(RC229):2002;1-5.
6. Bonner T. The molecular basis of muscarinic acetylcholine receptor diversity. Trends Neurosci. 12:1989;148-151.
7. Bonner T., Young A., Brann M. Cloning and expression of the human and rat m5 muscarinic receptor genes. Neuron. 1:1988;403-410.
8. Brain S.J., Morris H., MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature. 313:1985;54-56.
9. Brain S., Williams T. Inflammatory edema induced by synergism between CGRP and mediators of increased vascular permeability. Br J Pharmacol. 86:1985;855-860.
10. Caulfield M.P. Muscarinic receptors: characterization, coupling and function. Pharmacol Ther. 58:1993;319-379.
11. Caulfield M.P., Birdsall N.G.M. International union pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev. 50:1998;279-290.
12. Clavelou P., Pajot J., Dallel R., Raboisson P. Application of the formalin test to the study of orofacial pain in the rat. Neurosci Lett. 103:1989;349-353.
13. Cruwys S.C., Kidd B.L., Mapp P.I., Walsh D.A., Blake D.R. The effects of calcitonin gene-related peptide on formation of intra-articular oedema by inflammatory mediators. Br J Pharmacol. 107:1992;116-119.
14. Dussor G.O., Leong A.S., Gracia N.B., Hargreaves K.M., Arneric S.P., Flores C.M. Differential effects of neuronal nicotinic receptor agonists on capsaicin-evoked CGRP release from peripheral terminals of primary sensory neurons. Eur J Neurosci. 18:2003;2515-2526.
15. Eisenach J.C. Muscarinic-mediated analgesia. Life Sci. 64:1999;549-554.
16. Flores C.M., Leong A.S., Dussor G.O., Harding-Rose C., Hargreaves K.M., Kilo S. Capsaicin-evoked CGRP release from rat buccal mucosa: development of a model system for studying trigeminal mechanisms of neurogenic inflammation. Eur J Neurosci. 14:2001;1113-1120.
17. Gazelius B., Edwall B., Olgart L., Lundberg J., Hokfelt T., Fischer J. Vasodilatory effects and coexistence of CGRP and substance P in sensory nerves of cat dental pulp. Acta Physiol Scand. 130:1987;33-40.
18. Gerzanich V., Peng X., Wang F., Wells G., Anand R., Fletcher S., Lindstrom J. Comparitive pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. J Pharmacol Exp Ther. 48:1995;774-782.
19. Gerzanich V., Kuryatov A., Anand A., Lindstrom J. 'Orphan' α6 nicotinic AChR subunit can form a functional heteromeric acetylcholine receptor. J Pharmacol Exp Ther. 51:1997;320-327.
20. Gillberg P.G., Nordberg A., Aquilonius S.M. Muscarinic binding sites in small homogenates and in autoradiographic sections from rat and human spinal cord. Brain Res. 300:1984;327-333.
21. Gopalakrishnan M., Buisson B., Touma E., Giordano T., Campbell J.E., Hu I.C., Donnelly-Roberts D., Arneric S.P., Bertrand D., Sullivan J.P. Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptor. Eur J Pharmacol. 290:1995;237-246.
22. Haberberger R., Henrich M., Couraud J.Y., Kummer W. Muscaarinic m2-receptors in rat thoracic dorsal root ganglia. Neurosci Lett. 266:1999;177-180.
23. Iwamoto E.T., Marion L. Adrenergic, serotonergic and cholinergic components of nicotinic antinociception in rats. J Pharmacol Exp Ther. 265:1993;777-789.
24. Janscó N., Janscó-Gabor A., Szolcsányi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol. 31:1967;138-151.
25. Karimian M., Ferrell W.R. Plasma protein extravasation into the rat knee joint induced by calcitonin gene-related peptide. Neurosci Lett. 166:1994;39-42.
26. Liu J., Evans M.S., Lee T.J. Presynaptic muscarinic m(2)-receptor- mediated inhibition of N-type Ca(2+) channels in cultured sphenopalatine ganglion: direct evidence for acetylcholine inhibition of cerebral nitrergic neurogenic vasodilation. J Pharmacol Exp Ther. 302:2002;397-405.
27. Molliver D.C., Wright D.E., Leitner M.L., Parsadanian A.S., Doster K., Wen D., Yan Q., Snider W.D. IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life. Neuron. 19:1997;849-861.
28. Peterson M.A., Basbaum A.I., Abbadie C., Rohde D.S., McKay W.R., Taylor B.K. The differential contribution of capsaicn-sensitive afferents to behavioral and cardiovascular measures of brief and persistent nociception and to Fos expression in the formalin test. Brain Res. 755:1997;9-16.
29. Shibata M., Ohkubo T., Takahashi H., Inoki R. Modified formalin test: characteristic biphasic pain response. Pain. 38:1989;347-352.
30. Silverman J.D., Kruger L. Selective neuronal glycoconjugate expression in sensory and autonomic ganglia: relation of lectin reactivity to peptide and enzyme markers. J Neurocytol. 19:1990;789-801.
31. Tata A.M., Vilaro M.T., Agrati C., Biagioni S., Mengod G., Augusti-Tocco G. Expression of muscarinic m2 receptor mRNA in dorsal root ganglia of neonatal rat. Brain Res. 824:1999;63-70.
32. Tata A.M., Vilaro M.T., Mengod G. Muscarinic receptor subtypes expression in rat and chick dorsal root ganglia. Mol Brain Res. 82:2000;1-10.
33. Vizi E.S., Somogyi G.T. Prejunctional modulation of acetylcholine release from the skeletal neuromuscular junction: link between positive (nicotinic)- and negative (muscarinic)-feedback modulation. Br J Pharmacol. 97:1989;65-70.
34. Wamsley J.K., Zarbin M.A., Kuhar M.J. Muscarinic cholinergic receptors flow in the sciatic nerve. Brain Res. 217:1981;155-161.
35. Wessler I. Control of transmitter release from the motor nerve by presynaptic nicotinic and muscarinic autoreceptors. Trends Pharmacol Sci. 10:1989;110-114.
36. Wessler I., Halank M., Rasbach J., Kilbinger H. Presynaptic nicotine receptors mediating a positive feed-back on transmitter release from the rat phrenic nerve. Naunyn-Schmiedeberg's Arch Pharmacol. 334:1986;365-372.